ChemicalBook > CAS DataBase List > 1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-

1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-

Product Name
1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-
CAS No.
1911644-32-0
Chemical Name
1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-
Synonyms
Ruxolitinib-amide;Ruxolitinib Impurity 6;Ruxolitinib Impurity 5;Ruxolitinib Impurity 25;1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-;Ruxolitinib-amideQ: What is Ruxolitinib-amide Q: What is the CAS Number of Ruxolitinib-amide Q: What is the storage condition of Ruxolitinib-amide
CBNumber
CB68288242
Molecular Formula
C17H20N6O
Formula Weight
324.39
MOL File
1911644-32-0.mol
More
Less

1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- Property

Melting point:
216-217°C
Density 
1.50±0.1 g/cm3(Predicted)
storage temp. 
-20°C Freezer, Under inert atmosphere
solubility 
Ethyl Acetate (Slightly), Methanol (Slightly)
pka
11.69±0.50(Predicted)
form 
Solid
color 
White to Off-White
Stability:
Unstable in Solution
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- Chemical Properties,Usage,Production

Uses

Ruxolitinib-amide is an impurity of Ruxolitinib. Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.

1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- Suppliers

Shanghai Kewel Chemical Co., Ltd.
Tel
021-64609169 18901607656
Fax
021-64609160
Email
greensnown@163.com
Country
China
ProdList
9906
Advantage
50
Hubei Yangxin Medical Technology Co., Ltd.
Tel
15374522761
Fax
QQ:2853117752
Email
3003392093@qq.com
Country
China
ProdList
8377
Advantage
55
Hefei fuya biotechnology co. LTD
Tel
18096409024
Email
sales02@foreversyn.com
Country
China
ProdList
1918
Advantage
58
Jiangsu Wansipu Technology Co., Ltd.
Tel
17826022701
Email
1485609990@qq.com
Country
China
ProdList
950
Advantage
58
QUALITY CONTROL SOLUTIONS LTD.
Tel
0755-66853366; 13670046396
Email
ORDERS@QCSRM.COM
Country
China
ProdList
24326
Advantage
58
Molcoo Chemicals Inc.
Tel
18627756402
Email
3001051413@qq.com
Country
China
ProdList
9548
Advantage
58
Shenzhen Roark Pharma-Tec Co., Ltd.
Tel
13128912434
Email
2880126944@qq.com
Country
China
ProdList
2577
Advantage
58
Cato Research Chemicals Inc.
Tel
020-81960175-877 18933936954
Email
tianwen.zhan@cato-chem.com
Country
China
ProdList
7735
Advantage
58
Shanghai Easy CDMO Co.,Ltd
Tel
021-61734564
Email
August@easycdmo.com
Country
China
ProdList
10030
Advantage
58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd
Tel
18162595016; 18162595016
Email
3287908757@qq.com
Country
China
ProdList
9122
Advantage
58
ShenZhen H&D Pharmaceutical Technology Co., LTD
Tel
13217415044
Email
wangshuai@hdimpurity.com
Country
China
ProdList
7095
Advantage
58
Cato Research Chemicals Inc.
Tel
13342851930
Email
3008394369@qq.com
Country
China
ProdList
15726
Advantage
58
Hubei Ruinuo Pharmaceutical Technology Co., Ltd
Tel
13165688766
Fax
0714-5316360
Email
3008058303@qq.com
Country
China
ProdList
3009
Advantage
58
ShenZhen H&D Pharmaceutical Technology Co., LTD
Tel
+8618627948422
Email
sale@hdimpurity.com
Country
China
ProdList
3389
Advantage
58
More
Less

View Lastest Price from 1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- manufacturers

ShenZhen H&D Pharmaceutical Technology Co., LTD
Product
Ruxolitinib Impurity 25 1911644-32-0
Price
US $0.00-0.00/mg
Min. Order
10mg
Purity
0.98
Supply Ability
10g
Release date
2024-04-23
ShenZhen H&D Pharmaceutical Technology Co., LTD
Product
Ruxolitinib Impurity 25 1911644-32-0
Price
US $0.00-0.00/mg
Min. Order
10mg
Purity
98%
Supply Ability
500mg
Release date
2024-08-06